The use of anthracycline-antibody complexes for specific antitumor activity.
Pietersz
G A
GA
Research Centre for Cancer and Transplantation, University of Melbourne, Parkville, Victoria, Australia.
Smyth
M J
MJ
Farquhar
I
I
McKenzie
C
C
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D004317:Doxorubicin / Q000494:pharmacology; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D014407:Tumor Cells, Cultured
D000903:Antibiotics, Antineoplastic; D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D004317:Doxorubicin